The role of pharmacist in early phase clinical research

The role of pharmacist in early phase clinical research

This article discusses the role of pharmacist in early phase clinical trials. Authors emphasize that in Russian phase I units pharmacists are rarely involved in clinical research activities. Probably the lack of regulatory documentation in this field is one of the main reasons. The opposite situatio...

Bibliográfalaš dieđut
Váldodahkkit:	A. V. Vozzhaev, S. B. Fitilev, V. A. Yakushev, I. I. Shkrebneva
Materiálatiipa:	Artihkal
Giella:	Russian
Almmustuhtton:	Izdatelstvo OKI 2018-05-01
Ráidu:	Качественная клиническая практика
Fáttát:	клинические исследования отделение i фазы роль провизора исследуемый препарат clinical trial phase i unit role of pharmacist investigational product
Liŋkkat:	https://www.clinvest.ru/jour/article/view/66

Geahča maid

Levosalbutamol and new opportunities for the treatment of bronchial asthma (review of the related studies)
Dahkki: A. A. Lidzhieva, et al.
Almmustuhtton: (2018-02-01)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
Dahkki: Marina V. Mayevskaya, et al.
Almmustuhtton: (2018-08-01)

Specific aspects of source medical documents in clinical studies on healthy volunteers
Dahkki: S. B. Fitilev, et al.
Almmustuhtton: (2018-05-01)

The problem of over-volunteering in early phase clinical trials
Dahkki: S. B. Fitilev, et al.
Almmustuhtton: (2018-07-01)

Pragmatic clinical trials
Dahkki: O. R. Shevchenko, et al.
Almmustuhtton: (2020-09-01)

Investigation of rubella vaccine maked MICROGEN Federal State Company: study I trial
Dahkki: A. N. Mironov, et al.
Almmustuhtton: (2011-02-01)

REASONS FOR Β-ADRENOBLOCKER USE IN ARTERIAL HYPERTENSION: ONE MORE TIME ABOUT PRO AND CONTRA
Dahkki: V. I. Makolkin
Almmustuhtton: (2016-01-01)

The role of reference intervals of laboratory tests in early phase clinical research in healthy volunteers
Dahkki: A. V. Vozzhaev, et al.
Almmustuhtton: (2018-07-01)

Подготовка специалистов в области проведения клинических исследований лекарственных средств в системе послевузовского профессионального образования врачей
Almmustuhtton: (2018-06-01)

OBSERVATIONAL TRAILS IN LIPIDOLOGY
Dahkki: S. A. Shalnova
Almmustuhtton: (2016-01-01)

The image of the ideal pharmacist in the opinions of the pharmaceutical students
Dahkki: M. Ye. Volchansky, et al.
Almmustuhtton: (2011-10-01)

NEWS FROM THE ANNUAL CONGRESS OF EUROPEAN SOCIETY OF CARDIOLOGY (BARCELONA 2014): REALIZED AND UNREALIZED EXPECTATIONS
Dahkki: S. Y. Martsevich, et al.
Almmustuhtton: (2015-09-01)

Пути минимизации систематических отклонений от протокола клинического исследования
Almmustuhtton: (2018-06-01)

Комбинированные конечные точки в клинических исследованиях: обзор публикаций
Almmustuhtton: (2018-06-01)

Информированное согласие в клинических испытаниях лекарственных средств
Almmustuhtton: (2018-06-01)

Объективизация достоверности при планировании и оценке результатов клинических исследований
Almmustuhtton: (2018-06-01)

Особенности терапевтического действия препарата ноотропного ряда Луцетам
Almmustuhtton: (2018-06-01)

Фармакодинамика и фармакокинетика нанонейрофармакологических препаратов
Almmustuhtton: (2012-03-01)

Risks of clinical trial protocol amendments according to duration of the trial
Dahkki: A. A. Eleskina, et al.
Almmustuhtton: (2023-07-01)

Guidelines of research biosimilar drugs
Dahkki: R. . Ivanov, et al.
Almmustuhtton: (2014-04-01)

Risks associated with the ethical aspects of conducting clinical trials
Dahkki: A. L. Khokhlov, et al.
Almmustuhtton: (2020-05-01)

Аудит клинического исследования
Almmustuhtton: (2018-06-01)

Есть ли будущее у рандомизированных исследований в сердечно-сосудистой хирургии в РФ?
Almmustuhtton: (2018-06-01)

Мониторинг клинического исследования
Almmustuhtton: (2018-06-01)

Клинические исследования в педиатрической практике
Almmustuhtton: (2018-06-01)

Оптимизация фармакотерапии хронической сердечной недостаточности с помощью отечественного β-адреноблокатора проксадола
Almmustuhtton: (2018-06-01)

Стратегия кризис-менеджмента клинических исследований
Almmustuhtton: (2018-06-01)

THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE
Dahkki: M. V. Lebedeva, et al.
Almmustuhtton: (2015-09-01)

QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL
Dahkki: E. L. Artanova, et al.
Almmustuhtton: (2015-12-01)

Современные направления научных исследований в женском спорте
Dahkki: Светлана Калытка
Almmustuhtton: (2016-11-01)

GCP inspection by Roszdravnadzor
Dahkki: E. S. Rogov, et al.
Almmustuhtton: (2018-06-01)

Modern approaches to herbal preparations efficacy and safety assessment in Russia and abroad
Dahkki: E. I. Sakanyan, et al.
Almmustuhtton: (2018-02-01)

CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1
Dahkki: V. V. Popov, et al.
Almmustuhtton: (2015-12-01)

CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2
Dahkki: V. V. Popov, et al.
Almmustuhtton: (2015-12-01)

Role of Informed Consent in a Decision-making on Participation in The Clinical Trial: Multicenter study in Russia “Face to Face”
Dahkki: O. I. Zvonareva, et al.
Almmustuhtton: (2016-10-01)

Заключительный отчет клинического исследования и практика публикаций
Almmustuhtton: (2018-06-01)

Основные результаты исследования ELSA
Almmustuhtton: (2018-06-01)

ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT?
Dahkki: L. N. Malay
Almmustuhtton: (2016-01-01)

IMMUNOINFLAMMATORY MECHANISMS OF THE FORMATION OF CHRONIC DUST BRONCHITIS IN MINERS
Dahkki: Николай Иванович Панев, et al.
Almmustuhtton: (2022-03-01)

Possibilities of adaptive design implementation in clinical trials of next-in-class drugs
Dahkki: N. V. Vostokova, et al.
Almmustuhtton: (2018-02-01)